Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Frequency of Neurologic Manifestations in COVID-19
Shubham Misra, Kavitha Kolappa, Manya Prasad, et al.
Neurology (2021) Vol. 97, Iss. 23
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
Lisa Bauer, Brigitta M. Laksono, Femke M.S. de Vrij, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 358-368
Open Access | Times Cited: 186
Convulsions in children with COVID‐19 during the Omicron wave
Jonas F. Ludvigsson
Acta Paediatrica (2022) Vol. 111, Iss. 5, pp. 1023-1026
Open Access | Times Cited: 76
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Francisco Carmona-Torre, Ane Mínguez‐Olaondo, A. López-Bravo, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 53
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19
Jennifer Frontera, Naomi M. Simon
JAMA Psychiatry (2022) Vol. 79, Iss. 8, pp. 811-811
Open Access | Times Cited: 50
Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia
Pardis Zarifkar, Costanza Peinkhofer, Michael E. Benros, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 48
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants
Lisa Bauer, Melanie Rissmann, Feline F. W. Benavides, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 44
Neurological consequences of COVID-19
Waldemar Brola, Maciej Wilski
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1208-1222
Open Access | Times Cited: 41
COVID-19-related headache and innate immune response — a narrative review
Marcin Straburzyński, Ewa Kuca-Warnawin, Marta Waliszewska‐Prosół
Neurologia i Neurochirurgia Polska (2022) Vol. 57, Iss. 1, pp. 43-52
Open Access | Times Cited: 38
Change in Seizure Incidence in Febrile Children With COVID-19 in the Era of Omicron Variant of Concern
Hiroyuki Iijima, M. Kubota, Chikara Ogimi
Journal of the Pediatric Infectious Diseases Society (2022) Vol. 11, Iss. 11, pp. 514-517
Open Access | Times Cited: 37
SARS-CoV-2 and the nervous system: current perspectives
Amrita Pattanaik, Sushma Bhandarkar B, Lonika Lodha, et al.
Archives of Virology (2023) Vol. 168, Iss. 6
Open Access | Times Cited: 33
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Ewa Rudnicka-Drożak, Paulina Drożak, Grzegorz Mizerski, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2146-2146
Open Access | Times Cited: 32
Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in COVID-19 Survivors: A Retrospective Cohort Study
Jue Tao Lim, Liang En Wee, An Ting Tay, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 1, pp. 70-79
Open Access | Times Cited: 27
Antiviral Therapy of COVID-19
Georgii Gudima, И.А. Кофиади, I.P. Shilovskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8867-8867
Open Access | Times Cited: 24
Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy
Ali Rafati, Yeganeh Pasebani, Melika Jameie, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 6, pp. 493-493
Open Access | Times Cited: 21
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS‐CoV‐2 infection
Alessia Nicotra, Federico Masserini, Francesca Calcaterra, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3968-3978
Open Access | Times Cited: 21
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis
Giorgia Giussani, Erica Westenberg, David García‐Azorín, et al.
Neuroepidemiology (2024) Vol. 58, Iss. 2, pp. 120-133
Closed Access | Times Cited: 9
Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection
Michelle Jagst, Lilli Pottkämper, André Gömer, et al.
Current Opinion in Microbiology (2024) Vol. 79, pp. 102474-102474
Open Access | Times Cited: 7
Neurological effects of COVID‐19 in infants and children
Carl E. Stafstrom
Developmental Medicine & Child Neurology (2022) Vol. 64, Iss. 7, pp. 818-829
Open Access | Times Cited: 29
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
Paul Lingor, Antonia F. Demleitner, Andreas Wolff, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1155-1167
Open Access | Times Cited: 29
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
Sarah Conway, Brian C. Healy, Jonathan Zurawski, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103946-103946
Open Access | Times Cited: 29
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations
Federico Verde, Ilaria Milone, Ilaria Bulgarelli, et al.
Journal of Neurology (2022) Vol. 269, Iss. 11, pp. 5691-5701
Open Access | Times Cited: 28
Viruses and amyloids - a vicious liaison
Per Hammarström, Sofie Nyström
Prion (2023) Vol. 17, Iss. 1, pp. 82-104
Open Access | Times Cited: 18
Pathogenetic and etiologic considerations of febrile seizures
Ji Yoon Han, Seung Beom Han
Clinical and Experimental Pediatrics (2023) Vol. 66, Iss. 2, pp. 46-53
Open Access | Times Cited: 16
The diversity in the clinical features of children hospitalized with COVID‐19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV‐2: Caution for neurological symptoms in Omicron variant
Aslıhan Şahin, Eda Karadağ Öncel, Osman Büyükşen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 16
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies
Margherita Bellucci, Federica Bozzano, Chiara Castellano, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top